user

COMPARING EFFICACY OF GUSELKUMAB VERSUS USTEKINUMAB IN MODERATE TO SEVERE PSORIASIS PATIENTS : AN ADJUSTED COMPARISON BASED ON VOYAGE 1&2 AND NAVIGATE TRIALS

被引：0
|
作者：
Diels, J. [1 ]
Thilakarathne, P. [1 ]
Schubert, A. [2 ]
McElligott, S. [3 ]
机构：
[1] Janssen Cilag, Beerse, Belgium
[2] Janssen Cilag Poland, Warsaw, Poland
[3] Janssen Sci Affairs LLC, Horsham, PA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.830
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY4
引用
收藏
页码：A544 / A545
页数：2
相关论文
共 50 条
  • [1] COMPARING EFFICACY OF GUSELKUMAB VERSUS USTEKINUMAB IN PATIENTS WITH PSORIASIS ARTHRITIS: AN ADJUSTED COMPARISON USING INDIVIDUAL PATIENT DATA FROM DISCOVER 1&2 AND PSUMMIT TRIALS
    Diels, J.
    Thilakarathne, P.
    Schubert, A.
    Hassan, F.
    Peterson, S.
    Noel, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1313 - 1313
  • [2] Comparing Efficacy of Guselkumab versus Ustekinumab in Patients with Psoriatic Arthritis: An Adjusted Comparison Using Individual Patient Data from DISCOVER 1&2 and PSUMMIT Trials
    Diels, Joris
    Thilakarathne, Pushpike
    Schubert, Agata
    Hassan, Fareen
    Peterson, Steven
    Noel, Wim
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3692 - 3693
  • [3] Efficacy of switching from ustekinumab to guselkumab in patients with moderate-to-severe plaque psoriasis: Results from the NAVIGATE study
    Langley, Richard G.
    Tsai, Tsen-Fang
    Flavin, Susan
    Song, Michael
    Randazzo, Bruce
    Wasfi, Yasmine
    Li, Shu
    Puig, Luis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB120 - AB120
  • [4] Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
    Hampton, Philip
    Borg, Emma
    Hansen, Jes Birger
    Augustin, Matthias
    PSORIASIS-TARGETS AND THERAPY, 2021, 11 : 123 - 131
  • [5] Comparing Efficacy of Guselkumab versus Ustekinumab in Patients with Psoriatic Arthritis: An Adjusted Comparison Using Individual Patient Data from the DISCOVER and PSUMMIT Trials
    Pushpike Thilakarathne
    Agata Schubert
    Steve Peterson
    Wim Noel
    Barkha P. Patel
    Fareen Hassan
    Rheumatology and Therapy, 2024, 11 : 457 - 474
  • [6] Comparing Efficacy of Guselkumab versus Ustekinumab in Patients with Psoriatic Arthritis: An Adjusted Comparison Using Individual Patient Data from the DISCOVER and PSUMMIT Trials
    Thilakarathne, Pushpike
    Schubert, Agata
    Peterson, Steve
    Noel, Wim
    Patel, Barkha P.
    Hassan, Fareen
    RHEUMATOLOGY AND THERAPY, 2024, 11 (02) : 457 - 474
  • [7] Clinician-reported PASI versus patient-reported symptoms and signs in moderate to severe psoriasis patients: Voyage 1&2 clinical trials
    Gordon, K.
    Han, C.
    Li, S.
    You, Y.
    Song, M.
    Fakharzadeh, S.
    Crowley, J.
    Reich, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 42 - 42
  • [8] Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies
    Gordon, K. B.
    Blauvelt, A.
    Foley, P.
    Song, M.
    Wasfi, Y.
    Randazzo, B.
    Shen, Y. K.
    You, Y.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 132 - 139
  • [9] Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2
    Armstrong, A.
    Eyerich, K.
    Conrad, C.
    Zhu, Y.
    Yang, Y. -w.
    Miller, M.
    You, Y.
    Shen, Y. -k.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1375 - E1379
  • [10] Characterization of super responders to guselkumab treatment in moderate to severe psoriasis: Results from the VOYAGE 1 and 2 clinical trials
    Reich, Kristian
    Strober, Bruce
    Langley, Richard
    Song, Michael
    Shen, Yaung-Kaung
    You, Yin
    Foley, Peter
    Blauvelt, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB145 - AB145
12345